Message-Id: <200504121258.j3CCwu1K009286@delorie.com>
Mailing-List: contact cygwin-help@cygwin.com; run by ezmlm
List-Subscribe: <mailto:cygwin-subscribe@cygwin.com>
List-Archive: <http://sourceware.org/ml/cygwin/>
List-Post: <mailto:cygwin@cygwin.com>
List-Help: <mailto:cygwin-help@cygwin.com>, <http://sourceware.org/ml/#faqs>
Sender: cygwin-owner@cygwin.com
Mail-Followup-To: cygwin@cygwin.com
Delivered-To: mailing list cygwin@cygwin.com
From: "Gary R. Van Sickle" <g.r.vansickle@worldnet.att.net>
To: <cygwin@cygwin.com>
Subject: RE: FDA-conform validation - any hints?
Date: Tue, 12 Apr 2005 08:01:22 -0500
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
In-reply-to: <KCEOLMMHICICJKHPFOALAEBADDAA.Jan.Schormann@BrainLAB.com>
X-IsSubscribed: yes

> -----Original Message-----
> From: cygwin-owner@cygwin.com 
> [mailto:cygwin-owner@cygwin.com] On Behalf Of Jan Schormann

> Jim and Gary,
> 
> thanks for your hints. Maybe I'm unnecessarily nervous.
> 
> I'm still working on a good definition for "enough"
> testing around the intended use, and to what level of detail 
> the intended use needs to be described.

A lot of that depends on what the product is (i.e. what class it is).  If
it's life-sustaining and/or implantable, "enough" takes on a whole different
meaning than if it's not.

>  With your comments, 
> I'm more confidently facing the FDA- challenge now with what 
> we have. Now I'm curious on the auditor's feedback - only a 
> few weeks left :-)
> 
> Not to forget: Many thanks for the effort to all of you who 
> make this tool, Cygwin, working. It's not so easy to make my 
> company give something in return, but one day I will.
> 

Good luck.

-- 
Gary R. Van Sickle

> So long,
> 	Jan.
> 
> > -----Original Message-----
> > From: Jim Drash [mailto:jim.drash@gmail.com]
> > Sent: Montag, 11. April 2005 20:51
> > To: Jan.Schormann@brainlab.com; cygwin@cygwin.com
> > Subject: Re: FDA-conform validation - any hints?
> >
> >
> > Jan:
> >
> > I work for a very large FDA-regulated company. Our FDA IT 
> audits have 
> > been centered on having documented processess and 
> appropriate sets of 
> > test protocols to show compliance to those processes.
> >
> > Your validation efforts around GNU tools must describe what is your 
> > intended use and how you would test that.  Please note that this is 
> > around your use of a given piece of software not anyone elses.
> >
> > So given that you are using some GNU tool as part of your process, 
> > then you the to have the proper work instructions and scope 
> statements 
> > around your use of the tool.
> >
> 
> 
> 
> --
> Unsubscribe info:      http://cygwin.com/ml/#unsubscribe-simple
> Problem reports:       http://cygwin.com/problems.html
> Documentation:         http://cygwin.com/docs.html
> FAQ:                   http://cygwin.com/faq/
> 


--
Unsubscribe info:      http://cygwin.com/ml/#unsubscribe-simple
Problem reports:       http://cygwin.com/problems.html
Documentation:         http://cygwin.com/docs.html
FAQ:                   http://cygwin.com/faq/

